ARUN KUMAR SINGH

Global Regulatory Affairs Analyst and Consultant - Life Sciences Analytics - AI-Powered RA - Healthcare Science - CLM

USFDA - EU MDR/IVDR - MHRA - Health Canada - TGA - CDSCO - ISO 13485 - IEC 62304 - ISO 14971 - SaMD - eCTD - Drug Delivery - Medical Device Pre/Post-Sales - Legal Acumen - Pharma Analytics - Regulatory Analytics

IND - NDA - BLA - ANDA - DMF - 510(k) - PMA - EUA SaMD - ISO 13485:2016 - IEC 62304 - ISO 14971:2019 EU MDR - IVDR - MHRA MIA - Health Canada - TGA AI-Powered RA - Predictive Analytics - Prompt Engineering Healthcare Science - Drug Delivery - Regulatory Analytics CLM - Icertis - Ironclad - Sirion - Agiloft ICD-10-CM - CPT - HCPCS - CMS-1500 - RCM
RA Website Resume Dashboard Certifications Legal Website Contact
Download Full Resume PDF Comprehensive RA Resume - Healthcare Science - Pharma Analytics - Regulatory Analytics - Medical Device - CLM - All Major Regulations and KPIs
Connect on LinkedIn - Life Sciences - Pharmaceutical - Drug Regulatory Affairs - SaMD - Medical Device - AI in RA - CLM - Healthcare Science Profile background: Pharmaceutical and Drug Regulatory Concept - Cardiology Device Portfolio - AI in Life Sciences - Multi-Jurisdiction RA
View LinkedIn Profile
About Me

RA Analyst - Healthcare Science - Pharma Analytics - Regulatory Analytics - Medical Device - Legal Acumen - AI Practitioner

I am a cross-functional Regulatory Affairs Analyst and Life Sciences Consultant with a uniquely rare combination: pharmaceutical commercial leadership (8 years), NABH-accredited clinical hospital operations and medical device pre/post-sales management (8 years), multi-jurisdiction RA intelligence across 6 global agencies, AI-powered regulatory analytics, healthcare science knowledge spanning drug delivery systems and PK/PD, and 7-year in-house corporate legal practice spanning 25+ years total.

My pharma career began launching first-in-India branded APIs - Clopidogrel, Fenofibrate, LMWHs (Parnaparin), Esmolol HCl (IV), Carvedilol - requiring deep drug mechanism, PK/PD, regulatory indication, labelling, and physician education knowledge across cardiology, diabetology, and general medicine in Eastern India.

At B.M. Birla Heart Research Centre (India's first NABH-accredited cardiac hospital), I led full pre-sales to post-sales collaboration with medical device companies across coronary stents (BMS/DES), pacemakers, cath lab devices, and cardiac valves - spanning the complete medical device regulatory lifecycle.

My legal acumen as Licensed Advocate, US Paralegal, and corporate legal practitioner transforms RA intelligence into enforceable contracts and risk-mitigated strategies. My AI-powered regulatory analytics practice delivers 40% documented efficiency gains using Harvey AI, ChatGPT-4, Lexis Plus AI, and Power BI daily.

First
In-India API launches - Clopidogrel, Parnaparin, Esmolol, Carvedilol (USV Ltd)
25%
CAGR pharma territory sales 8 years - Eastern India
30%
Institutional revenue growth - NABH cardiac hospital SBU Head
200+
KOLs acquired - cardiologists and interventionalists
40%
AI-powered research efficiency gain - daily practitioner
6+
Jurisdictions - USFDA EU MHRA TGA HC CDSCO
Core Skills and Expertise

Click any section to expand full details - all major competency domains

Healthcare Science - Life Sciences - Drug Delivery - Pharmacology - Regulatory Analytics KEY DOMAIN ▼

Healthcare Science and Drug Delivery Systems (Hands-on Commercial and Clinical Experience):

  • Drug Delivery Systems: Oral antiplatelet (Clopidogrel P2Y12), oral lipid-lowering (Fenofibrate PPAR-alpha), subcutaneous injectable LMWH (Parnaparin Sodium - cold chain, sterility assurance), IV ultra-short beta-1 blocker (Esmolol HCl - critically important delivery mechanism for acute cardiac care), oral alpha/beta blocker (Carvedilol - extended release formulation intelligence).
  • PK/PD Applied Knowledge: ADME principles (absorption, distribution, metabolism, excretion) applied in physician scientific detailing; bioavailability and bioequivalence (BA/BE); half-life, Tmax, Cmax, AUC - communication to cardiologists and diabetologists. Drug delivery system selection impacts CMC module requirements, stability data expectations, and labelling obligations across all jurisdictions.
  • Clinical Operations: NABH-accredited cardiac hospital SBU management; patient outcome tracking; adverse event awareness and vigilance; CME organisation; KOL mapping and acquisition; cardiac cath lab, pacemaker, coronary stent BMS/DES, cardiac valve pre/post-sales collaboration - spanning the entire Medical Device commercial and regulatory lifecycle.
  • Regulatory Analytics: AI-powered predictive models for submission success probability and drug approval timeline forecasting; eCTD/CTD gap analysis using GenAI; pharmacovigilance analytics including AI-assisted ICSR processing and adverse event signal detection; real-world evidence (RWE) analysis; PSUR/PBRER intelligence automation; Power BI regulatory submission tracking dashboards; physician Rx behaviour analytics for market intelligence.
  • Healthcare IT and Medical Coding: ICD-10-CM diagnosis coding (cardiology I-codes, diabetology, GM); CPT (cardiac catheterisation, interventional cardiology); HCPCS Level II (LMWH J-codes, DME); WHO-ICH MedDRA for pharmacovigilance adverse event coding; CMS-1500 abstraction and filing; Revenue Cycle Management (RCM); AR management; HIPAA 837P transaction sets.
Drug Delivery SystemsPK/PD AppliedADMEBioequivalenceRegulatory AnalyticsPredictive AlgorithmsPharmacovigilance AIRWE AnalysisICD-10-CMCMS-1500 RCM
Pharmaceutical and Life Sciences Analytics - AI-Powered Research - Predictive Algorithms CUTTING EDGE 2025 ▼

At the frontier of pharma analytics, developing and deploying AI-powered research frameworks, predictive algorithms, and data-driven intelligence tools. McKinsey-Merck 2025 confirms GenAI reduces CSR writing time from 180 to 80 hours with 50% fewer errors.

  • Predictive Algorithm Development: Outcome-prediction models for regulatory submission success probability, drug approval timeline forecasting, adverse event signal detection, and market penetration analytics using machine learning principles and advanced prompt engineering on GPT-4 and Claude.
  • AI in Drug Discovery: GenAI for literature synthesis, target identification, drug repurposing intelligence, ADME/PK prediction review, and CSR first-draft generation aligned with FDA January 2025 AI guidance and EMA Reflection Paper on AI.
  • Pharmacovigilance Analytics: AI-assisted ICSR processing, adverse event signal detection, RWE analysis, PSUR/PBRER intelligence - aligned with CIOMS Working Group XIV 2025 AI in PV framework and FDA EDSTP programme.
  • Market Intelligence and Rx Analytics: Physician prescription behaviour analysis, market share modelling, doctor psychology segmentation, territory performance analytics, and KOL network mapping - validated by 8 years hands-on field execution across Eastern India.
  • Regulatory Intelligence Dashboards: Power BI for submission tracking, compliance KPI visualisation, regulatory timeline modelling, agency query analytics, and post-approval lifecycle reporting across FDA, EMA, MHRA, HC, TGA, CDSCO.
Predictive AlgorithmsGenAI in PharmaPharmacovigilance AIPower BIRx Behaviour AnalysisMarket IntelligenceADME AnalyticsAI Signal DetectionRWE Analysis
AI Tools - Prompt Engineering - Algorithm Creation - Daily Practice ▼
  • Harvey AI: Regulatory document analysis, FDA guidance interpretation, gap identification in submission dossiers, risk assessment automation.
  • Lexis Plus AI and Casetext CoCounsel: Literature searches, regulatory decision history, drug approval precedent research, clinical evidence synthesis.
  • ChatGPT-4 and Claude: eCTD module drafting, SOP generation, ISO 14971 risk management report drafts, regulatory gap analyses, predictive outcome modelling, prompt chains for multi-step regulatory workflows.
  • Power BI: Regulatory submission tracking dashboards, compliance KPI monitoring, adverse event trend analysis.
  • n8n Automation: Contract drafting automation, compliance deadline management, regulatory alert workflows.
  • FDA Elsa (June 2025) and EMA Scientific Explorer: Agency-wide GenAI tools adopted by regulators - critical for understanding AI-augmented regulatory review processes when planning submissions.
Harvey AILexis Plus AIChatGPT-4ClaudePower BIn8n AutomationPrompt Engineering
Global Regulatory Submissions - USFDA - EU MDR - MHRA - TGA - Health Canada - CDSCO ▼
  • USFDA CDER: IND, NDA (21 CFR 314), BLA (21 CFR 601), ANDA, DMF, EUA, AND, NID, eCTD (ICH M4 Modules 1-5), COSM, ESG Filing.
  • USFDA CDRH: 510(k) Premarket Notification, PMA, De Novo, Q-Sub, IVD, Design Controls (21 CFR 820.30), QMSR (Feb 2026 - incorporates ISO 13485:2016 by reference).
  • EU MDR and IVDR: Class I, IIa, IIb, III devices; CE Marking; Notified Body; Technical Documentation; EUDAMED; Clinical Evaluation Reports.
  • MHRA (UK): MIA, MS, MIA(IMP), WDA(H), DORS, EDQM CEP, DPO Register.
  • Health Canada: eCTD NDS/ANDS; CTA; Medical Devices Class II-IV; NOC.
  • TGA (Australia): Category 1, 2, 3; OTC; Medical Devices Class I, IIa, IIb, IVD; SAR; ARTG.
  • CDSCO (India): Form 40 and 10; CT-04; NDA CT-21/CT-23; MDR 2017; SUGAM portal; CTRI Phase I-IV; Schedule Y; PvPI; PMS.
IND/NDA/BLA/ANDA510(k)/PMAEU MDR/IVDRMHRA MIAeCTD/CTDCDSCO SUGAMHealth Canada
SaMD - QMS Standards - ISO 13485 - IEC 62304 - ISO 14971 - EU AI Act ▼
  • ISO 13485:2016: QMS for Medical Devices - incorporated by FDA QMSR (Feb 2026); design controls, CAPA, supplier management.
  • IEC 62304: Software Lifecycle Processes - Class A/B/C (Edition 2: two-rigor-level model); SOUP management; configuration control.
  • ISO 14971:2019: Risk Management - FMEA, hazard analysis, risk-benefit; integrated with IEC 62304 fault trees.
  • IEC 82304-1: Health Software Safety; IEC 62366-1: Usability Engineering - human factors, use error risk analysis.
  • EU AI Act 2024: High-risk AI for SaMD - dual MDR and AI Act compliance required from 2026-2027.
  • ICH E6 R2, Q8, Q9, Q10: GCP, Quality by Design, Quality Risk Management, Pharmaceutical Quality System.
ISO 13485:2016IEC 62304ISO 14971:2019SaMD ClassificationEU AI Act 2024GxP Compliance
Medical Device Pre-Sales to Post-Sales - Cardiology Portfolio - NABH Hospital ▼
  • Device Categories (hands-on): Coronary stents BMS/DES, cardiac pacemakers, cath lab devices (guiding catheters, balloon catheters, guide wires), cardiac valves (mechanical and bioprosthetic) - all with direct vendor collaboration experience.
  • Pre-Sales: KOL mapping, physician relationship development, scientific detailing, CME organisation, clinical evidence presentation, competitor analysis, market sizing, institutional market development at hospital and cath lab level.
  • Post-Sales and Post-Market: Patient outcome tracking, adverse event awareness, NABH compliance for device usage, vendor SLA management, device procurement negotiations, post-market surveillance awareness applicable to MDR 2017 and FDA 21 CFR 803.
  • Regulatory Awareness: MDR 2017 (CDSCO) Class II/III devices; CE Marking for imported devices; FDA 510(k)/PMA classification relevance for commercial device types - enabling direct conversation with RA teams about device compliance.
Coronary Stents BMS/DESCardiac PacemakersCath Lab DevicesKOL AcquisitionPost-Market Surveillance
Legal Acumen - Corporate Compliance - Regulatory-Legal Intersection - US Paralegal ▼
  • Regulatory Legal Drafting: CTAs, Site CDAs, CRO/CMO service agreements, Medical Device distribution agreements, Pharmacovigilance agreements, License agreements, Technology Transfer Agreements - 300+ agreements with 85% litigation success rate.
  • Compliance Frameworks: Companies Act 2013, DPDP Act 2023, PMLA 2002, FEMA 1999, Consumer Protection Act 2019, NABH Standards, Clinical Establishments Act 2010.
  • Legal Risk in RA: Patent cliff analysis, FTO (Freedom-to-Operate), data exclusivity periods, orphan drug designation, recall liability, post-market vigilance legal obligations, FDA 483/Warning Letter legal response strategy.
  • US Legal Context: US Paralegal and Contract Drafting (Innovation School Canada) - FDA enforcement actions, import alerts - legal response strategy applicable to pharma and medical device companies seeking US market access.
CTA DraftingCRO/CMO AgreementsFDA 483 ResponsePatent and FTODPDP Act 2023US Paralegal Cert.
Medical Coding - RCM - ICD-10-CM - CPT - HCPCS - CMS-1500 - MedDRA ▼
  • ICD-10-CM: Diagnosis coding - cardiology (I-codes), diabetology, general medicine; FY2025 updates; code sequencing; laterality; specificity requirements.
  • CPT: Cardiac catheterisation codes, interventional cardiology procedures, evaluation and management levels.
  • HCPCS Level II: Injectable drugs (LMWH J-codes), durable medical equipment; CMS fee schedules.
  • WHO-ICH and MedDRA: Preferred terms, system organ class coding for adverse event reporting in clinical trials and pharmacovigilance - bridging medical coding and RA.
  • CMS-1500 and RCM: Clean claim submission, abstraction, denial management, AR follow-up, payer contract intelligence, HIPAA 837P transaction sets.
ICD-10-CMCPTHCPCSMedDRACMS-1500RCM/AR
Contract Management and Contract Lifecycle Management (CLM)

Full CLM lifecycle expertise across pharmaceutical, medical device, and life sciences - from initiation through analytics

Contract Lifecycle Management - Full Process - Pharma-Specific Contract Types - Leading Platforms ▼
  • Initiation and Authoring: Clause library management, automated template-based drafting, regulatory-specific clause insertion (indemnity, IP assignment, data protection, pharmacovigilance obligations, GxP requirements).
  • Review and Negotiation: Redlining, version control, multi-party review workflows, AI risk scoring, approval routing via automated workflows.
  • Execution and e-Signature: DocuSign, Spellbook, Ironclad signature workflows; GxP-compliant electronic signature under 21 CFR Part 11; audit trail generation.
  • Obligation Management: Milestone tracking, payment obligation monitoring, regulatory reporting deadlines, renewal alerts, SLA compliance monitoring.
  • Pharma Contract Types: Clinical Trial Agreements (CTAs), Site CDAs, CRO/CMO Agreements, Pharmacovigilance Agreements, Technology Transfer Agreements, API Supply Agreements, Distribution Agreements, Medical Device Service Agreements, License Agreements with royalty structures, Co-Promotion Agreements.
  • Leading Platforms (2025 Gartner Magic Quadrant): Icertis (5 of top 7 pharma companies; Gartner Leader 5 years), Sirion (AI-native agentic CLM), Ironclad (1B+ contracts; Gartner Leader), Agiloft (no-code; GxP compliance), DocuSign CLM with Evisort AI, Conga CLM (Salesforce-native), ContractPodAi/Leah (Agentic CLM), Spellbook/Kira (in-Word AI drafting).
CLM Full LifecycleClause Library21 CFR Part 11 e-SignAI Contract AnalyticsCTA and CRO AgreementsPV Agreements
PlatformKey StrengthPharma Use CaseAI CapabilityBest For
Icertis5 of top 7 pharma companies; Gartner Leader 5 years runningCTA management, CRO/CMO, API supply, royalty structures, PV agreementsAdvanced AI tagging, NLP clause extraction, risk scoring, obligation analyticsPharmaLegal
Sirion (AI-Native)Agentic architecture; highest analyst ratings in 9 areas; post-signature performance focusSupplier lifecycle, obligation tracking, pharma distribution agreementsAgentic AI extraction, semantic search, structured data layerLife SciencesAI-Native
Ironclad CLMGartner Leader; 1B+ contracts processed; visual workflow builder; Salesforce integrationNDA/CDA management, legal team efficiency, digital agreementsAI tagging, automated data extraction, risk identificationEnterpriseLegal
Agiloft CLMNo-code customisation; 99.6% implementation success; regulated industries specialistHealthcare compliance contracts, GxP audit trails, HIPAA/GDPR complianceAI risk scoring, ConvoAI natural language search, generative redliningHealthcareCompliance
DocuSign CLM + EvisortE-signature plus CLM; Workday-powered Evisort AI; broad enterprise adoptionMulti-party trial agreements, GxP-compliant e-signature workflowsEvisort AI data extraction, obligation monitoring, intelligent searchPharmaAll Sectors
Conga CLMSalesforce-native; clause library; CPQ integration for sales-driven contractingDrug commercialisation contracts, co-promotion agreements, CRM-integrated dealsDynamic templates, AI clause suggestions, automated approvals in SalesforcePharma SalesCRM
ContractPodAi / LeahAgentic CLM - AI authoring plus workflows plus advanced semantic search unifiedEnd-to-end pharma contract intelligence and generative drafting for regulatory agreementsLeah Agentic CLM - AI-powered authoring, automated workflows, semantic searchLife SciencesAgentic AI
Spellbook / KiraIn-Word AI drafting; real-time clause suggestions; rapid redlining for legal practitionersDay-to-day NDAs, employment contracts, supplier terms - daily practitioner useGenerative AI clause drafting, automated redlining, risk flagging within MS WordLegal TeamsSME Pharma
Global Regulatory Body Directory

Direct links to all major regulatory agencies and submission portals

FDA - CDER (USA)
Center for Drug Evaluation and Research
INDNDABLAANDADMFEUA
eCTD - AND - NID - COSM - ESG Filing - ICH M4
Visit CDER
FDA - CDRH (USA)
Center for Devices and Radiological Health
510(k)PMADe NovoSaMDIVD
QMSR - 21 CFR 820 - Design Controls - Post-Market MDR
Visit CDRH
FDA AccessData (USA)
Drug and Device Approval Databases
Drugs@FDA510k DBDailyMed
Orange Book - Purple Book - Device Classification - MAUDE
AccessData
EMA (EU)
European Medicines Agency
EU MDRIVDRMAAEPAR
CE Marking - Notified Body - CER - PMCF - EUDAMED
Visit EMA
EDQM (EU)
European Directorate for Quality of Medicines
CEPAPI Ref.Ph.Eur.
Certificate of Suitability - European Pharmacopoeia
Visit EDQM
MHRA (UK)
Medicines and Healthcare Products Regulatory Agency
MIAMSMIA(IMP)WDA(H)
DORS - Manufacturing Authorisation - DPO Register
Visit MHRA
Health Canada
Health Products and Food Branch (HPFB)
eCTDNDSANDSCTA
Medical Devices Class II-IV - NOC - Drug Product Database
Visit Health Canada
TGA (Australia)
Therapeutic Goods Administration
Cat 1/2/3OTCSAR
Medical Devices Class I-IVD - ARTG - Biologicals
Visit TGA
CDSCO (India)
Central Drugs Standard Control Organisation
Form 40/10CT-04MDR 2017
NDA CT-21/CT-23 - Schedule Y - D and C Act 1940
Visit CDSCO
SUGAM Portal (India)
CDSCO Digital Submission Portal
Digital Sub.Online RA
Online Drug and Device Submissions - Form Filing - Status Tracking
Visit SUGAM
CTRI (India)
Clinical Trials Registry - India
Phase I-IVPMSVigilance
Trial Registration - ADR Reporting - PvPI - Post-Marketing Surveillance
Visit CTRI
ICH (Global)
International Council for Harmonisation
E6 R2Q8/Q9/Q10M4 CTD
GCP - Quality Risk Management - M7 Genotoxic Impurities
Visit ICH
IMDRF (Global)
International Medical Device Regulators Forum
SaMDMDSAP
SaMD Classification Framework - MDSAP - Global Harmonisation
Visit IMDRF
ISO and IEC (Global)
International Organization for Standardization
ISO 13485IEC 62304ISO 14971
QMS - Software Lifecycle - Risk Management - Usability
Visit ISO
WHO (Global)
World Health Organization
ICD-10/11MedDRAGxP
Prequalification - ATC Classification - GMP Guidelines
Visit WHO
CMS (USA)
Centers for Medicare and Medicaid Services
ICD-10-CMCPTHCPCSCMS-1500
Revenue Cycle Management - AR Management - Medical Record Abstraction
Visit CMS
The Unique Value - Where Law, RA, Pharma, Healthcare Science and AI Converge

Why this combination creates uniquely invaluable insights for life sciences, healthcare, pharmaceutical, and medical device industries

Healthcare Science to RA

  • Drug delivery system selection impacts CMC module strategy
  • PK/PD knowledge enables clinical section review
  • ADME and bioequivalence directly relevant to ANDA and BE studies
  • NABH hospital experience bridges QMS to real clinical operations
  • Cardiac device collaboration enables 510(k)/PMA context understanding

Regulatory Analytics to Decisions

  • Predictive algorithms for submission success probability
  • AI-assisted eCTD gap analysis and module completeness
  • Pharmacovigilance analytics - AI signal detection and RWE
  • Power BI regulatory dashboards for C-suite visibility
  • Market intelligence analytics for NDA/BLA commercial sections

Legal Acumen to RA Strategy

  • Contract interpretation through regulatory lens
  • IP protection aligned with RA exclusivity timelines
  • Regulatory legal drafting - CTAs, PV Agreements, CRO/CMO
  • FDA 483 and Warning Letter legal response strategy
  • Patent cliff and data exclusivity legal and RA intersection

Pharma Field to Regulatory Intelligence

  • First-in-India API launches - RA from commercial side
  • Physician psychology analysis for clinical evidence packaging
  • Territory analytics for NDA/BLA commercial sections
  • Distribution monitoring for supply chain RA compliance
  • CME organisation bridges medical affairs and MSL roles

Medical Device Pre/Post-Sales to RA

  • BMS/DES stent portfolio - 510(k)/PMA commercial context
  • Cath lab device collaboration - clinical evaluation evidence
  • Post-sales patient outcomes - PMS and vigilance obligations
  • Device vendor negotiations - ISO 13485 supplier qualification
  • NABH compliance - QMS principles in real clinical setting

AI Plus CLM Plus Legal Advantage

  • 40% research efficiency - Harvey AI, Lexis Plus AI, ChatGPT-4
  • GenAI-assisted eCTD module drafting and gap analysis
  • 300 plus contracts - regulatory, commercial, clinical
  • GxP-compliant e-signature - 21 CFR Part 11
  • Icertis, Ironclad, Sirion, Agiloft platform knowledge
Blog - Write, Save and Publish Regulatory Insights

All posts saved in your browser permanently. Click any post to read full text. Use Write tab to add new posts anytime.

All Posts
Write New Post
0
Total posts
--
Latest post
--
Top category
0
Words written
Editing existing post - changes will update on save
0/140
0/160
0/10000 - 0 words
back to all posts
Contact and Links

Open to RA Analyst, RA Consultant, Life Sciences IT, Medical Device RA, Pharma Analytics, Healthcare Science, and CLM roles globally

Emailesqaks@gmail.com

Phone+91 62902 40024

LocationSerampore, Kolkata, West Bengal, India

ModeGlobal Remote / Hybrid / Relocation

AvailableImmediately available

Target Roles

RA Analyst - RA Consultant - Medical Device RA - SaMD RA Specialist - Life Sciences IT RA - Pharma Analytics - Healthcare Science Analyst - Regulatory Analytics - CLM Manager - Medical Coding Specialist - RCM Analyst - Pharmacovigilance Analyst - Medical Affairs - MSL Support